The embarrassing result of the investigation into the breaches by the Prescription Medicines Code of Practice Authority (PMCPA) follows a decision by Novo Nordisk’s UK general manager ...

"Novo Nordisk is proud to lead the industry in sustainable business practices, doing our part to give empty pens new purpose," said the company's UK general manager, Pinder Sahota. "As part of our ...

Pick the best stocks and maximize your portfolio: Novo Nordisk ( (NVO)) has provided an update. Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human ...

GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to ...

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

Novo Nordisk’s blockbuster drug Ozempic got another star added to its label Thursday, in an encouraging sign for the ...

LAB eN 2, the drug discovery accelerator launched by Evotec and Novo Nordisk in September 2023, has unveiled its first three ...

EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

(RTTNews) - Novo Nordisk A/S (NVO), Thursday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has supported label update for weight-loss drug ...

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

Evotec and Novo Nordisk launched LAB eN² in September 2023 to nurture early research from academic institutions into novel therapeutics.

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...